Transcriptome analysis of endocrine tumors: Clinical perspectives - 06/05/08
Abstract |
There is considerable interest in the application of DNA microarrays to the pathologic evaluation of endocrine neoplasms. Improvements in tumor classification and prognostication, prediction of response to therapy, and comprehensive assessment of tumoral hormone production represent the major anticipated benefits. Here, some of the microarray studies that support the clinical use of transcriptome profiling for endocrine tumors are reviewed. In addition, some of the barriers to clinical implementation are discussed.
El texto completo de este artículo está disponible en PDF.Keywords : Adrenal, Thyroid, Parathyroid, Endocrine pancreas, Pituitary, DNA microarray, Gene expression
Esquema
Vol 69 - N° 2
P. 130-134 - avril 2008 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.